XML 44 R50.htm IDEA: XBRL DOCUMENT
v2.4.0.8

9. COMMITMENTS AND CONTINGENCIES (Details Narrative) (USD $) | 12 Months Ended
--- | ---
Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2011
Research and development expense | $ 12,681,049 | $ 10,368,695 | $ 11,745,629
Rent expense, including amortization of deferred rent | 2,651,460 | 2,659,532 | 2,667,296
Total deferred rent asset | 6,047,098 | 6,591,126 |
Deferred rent asset, non-current | 5,448,381 | 5,939,358 |
R & D deferred rent liability | 3,992 | 1,033 |
Deferred rent liability | 12,412 | 15,479 |
Ergomed Collaborative Arrangement |  |  |
Research and development expense | $ 838,000 |  |

X
- Definition Custom Element. + References No definition available. + Details
Name: | CVM_DeferredRentLiability
Namespace Prefix: | CVM_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Deferred Rent Net Of Current Portion. + References No definition available. + Details
Name: | CVM_DeferredRentNetOfCurrentPortion
Namespace Prefix: | CVM_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition No authoritative reference available. + References No definition available. + Details
Name: | CVM_RDDeferredRentLiability
Namespace Prefix: | CVM_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition No authoritative reference available. + References No definition available. + Details
Name: | CVM_TotalDeferredRentAsset
Namespace Prefix: | CVM_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of rent expense incurred for leased assets, including but not limited to, furniture and equipment, that is not directly or indirectly associated with the manufacture, sale or creation of a product or product line. + References No definition available. + Details
Name: | us-gaap_LeaseAndRentalExpense
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 985 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 730 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373 + Details
Name: | us-gaap_ResearchAndDevelopmentExpense
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration